Literature DB >> 27111714

Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways.

Anastasia V Suhovskih1,2, Vladimir I Kashuba1,3, George Klein1, Elvira V Grigorieva1,2.   

Abstract

Microenvironment and stromal fibroblasts are able to inhibit tumor cell proliferation both through secreted signaling molecules and direct cell-cell interactions but molecular mechanisms of these effects remain unclear. In this study, we investigated a role of cell-cell contact-related molecules (protein ECM components, proteoglycans (PGs) and junction-related molecules) in intercellular communications between the human TERT immortalized fibroblasts (BjTERT fibroblasts) and normal (PNT2) or cancer (LNCaP, PC3, DU145) prostate epithelial cells. It was shown that BjTERT-PNT2 cell coculture resulted in significant decrease of both BjTERT and PNT2 proliferation rates and reorganization of transcriptional activity of cell-cell contact-related genes in both cell types. Immunocytochemical staining revealed redistribution of DCN and LUM in PNT2 cells and significant increase of SDC1 at the intercellular contact zones between BjTERT and PNT2 cells, suggesting active involvement of the PGs in cell-cell contacts and contact inhibition of cell proliferation. Unlike to PNT2 cells, PC3 cells did not respond to BjTERT in terms of PGs expression, moderately increased transcriptional activity of junctions-related genes (especially tight junction) and failed to establish PC3-BjTERT contacts. At the same time, PC3 cells significantly down-regulated junctions-related genes (especially focal adhesions and adherens junctions) in BjTERT fibroblasts resulting in visible preference for homotypic PC3-PC3 over heterotypic PC3-BjTERT contacts and autonomous growth of PC3 clones. Taken together, the results demonstrate that an instructing role of fibroblasts to normal prostate epithelial cells is revoked by cancer cells through deregulation of proteoglycans and junction molecules expression and overall disorganization of fibroblast-cancer cell communication.

Entities:  

Keywords:  extracellular matrix; fibroblast; junction molecules; microenvironment; prostate cancer; proteoglycan

Mesh:

Substances:

Year:  2016        PMID: 27111714      PMCID: PMC5308224          DOI: 10.1080/19336918.2016.1182292

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  66 in total

1.  Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer.

Authors:  C Ricciardelli; K Mayne; P J Sykes; W A Raymond; K McCaul; V R Marshall; D J Horsfall
Journal:  Clin Cancer Res       Date:  1998-04       Impact factor: 12.531

2.  Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts.

Authors:  J N Kabalin; D M Peehl; T A Stamey
Journal:  Prostate       Date:  1989       Impact factor: 4.104

Review 3.  Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts.

Authors:  Yali Han; Yanwen Zhang; Tanghong Jia; Yuping Sun
Journal:  Tumour Biol       Date:  2015-02-15

4.  Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.

Authors:  Harold J Ting; Gagan Deep; Anil K Jain; Adela Cimic; Joseph Sirintrapun; Lina M Romero; Scott D Cramer; Chapla Agarwal; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2014-02-24       Impact factor: 4.784

5.  Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment.

Authors:  Erika L Spaeth; Adam M Labaff; Bryan P Toole; Ann Klopp; Michael Andreeff; Frank C Marini
Journal:  Cancer Res       Date:  2013-07-09       Impact factor: 12.701

6.  The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.

Authors:  Hector R Contreras; Rodrigo A Ledezma; Jorge Vergara; Federico Cifuentes; Cristina Barra; Pablo Cabello; Ivan Gallegos; Bernardo Morales; Christian Huidobro; Enrique A Castellón
Journal:  Urol Oncol       Date:  2009-05-17       Impact factor: 3.498

7.  Lumican expression, localization and antitumor activity in prostate cancer.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Claudia A Andrade de Paula; Celia R W Carneiro; Valdemar Ortiz; Leny Toma; Winston W-Y Kao; Helena B Nader
Journal:  Exp Cell Res       Date:  2013-02-08       Impact factor: 3.905

8.  Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer.

Authors:  Nicole Paland; Iris Kamer; Ira Kogan-Sakin; Shalom Madar; Naomi Goldfinger; Varda Rotter
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

9.  Tumor microenvironment indoctrination: an emerging hallmark of cancer.

Authors:  Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

10.  Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways.

Authors:  Yunping Hu; Haiguo Sun; Rick T Owens; Jiansheng Wu; Yong Q Chen; Isabelle M Berquin; Donna Perry; Joseph T O'Flaherty; Iris J Edwards
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

View more
  6 in total

1.  Intratumor δ-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression.

Authors:  Mingchuan Li; Jongdee Nopparat; Byron J Aguilar; Yan-Hua Chen; Jiao Zhang; Jie Du; Xin Ai; Yong Luo; Yongguang Jiang; Christi Boykin; Qun Lu
Journal:  Oncogene       Date:  2020-04-20       Impact factor: 9.867

2.  Deep Sequencing of Complex Proteoglycans: A Novel Strategy for High Coverage and Site-specific Identification of Glycosaminoglycan-linked Peptides.

Authors:  Joshua A Klein; Le Meng; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2018-05-17       Impact factor: 5.911

3.  Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.

Authors:  Bianca Cioni; Ekaterina Nevedomskaya; Monique H M Melis; Johan van Burgsteden; Suzan Stelloo; Emma Hodel; Daniele Spinozzi; Jeroen de Jong; Henk van der Poel; Jan Paul de Boer; Lodewyk F A Wessels; Wilbert Zwart; Andries M Bergman
Journal:  Mol Oncol       Date:  2018-07-10       Impact factor: 6.603

4.  Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use.

Authors:  Qingyuan Qu; Ying Li; Xiaosheng Fang; Lingyan Zhang; Chao Xue; Xueling Ge; Xin Wang; Yujie Jiang
Journal:  Biol Direct       Date:  2019-11-27       Impact factor: 4.540

Review 5.  Patterns of indolence in prostate cancer (Review).

Authors:  Minas Sakellakis; Laura Jacqueline Flores; Sumankalai Ramachandran
Journal:  Exp Ther Med       Date:  2022-03-28       Impact factor: 2.447

Review 6.  Biological and Clinical Aspects of Metastatic Spinal Tumors.

Authors:  Jakub Litak; Wojciech Czyżewski; Michał Szymoniuk; Leon Sakwa; Barbara Pasierb; Joanna Litak; Zofia Hoffman; Piotr Kamieniak; Jacek Roliński
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.